University of Georgia

Under the Phenotypic Drug Discovery program, researchers from academia or biotech submit candidate compounds in specific therapeutic areas for Lilly to evaluate and profile. Participating organizations retain full IP rights to the compounds, but Lilly receives first rights to negotiate a broader collaboration or licensing agreement.

The first closing comprises a $7.5 million investment from the state — about $2.5 million less than originally planned — and $11.25 million from private investors. The fund will invest in companies with technologies developed at the six GRA member academic institutions.

The university will lead a multi-center study of large flowering plants seeking genetics behind certain traits.

BioArray Briefs

Premium

Febit, READNA Consortium, US Department of Agriculture, Autogenomics, Oxford Gene Technology, Optra, Gene Logic, Genstruct, Global Biomarker Conference

The Animal Genome Program will support studies in 15 states for disease and genetics studies.

Short Reads

Premium

Broad Institute, Expression Analysis, Helicos BioSciences, University of Texas at Austin, Applied Biosystems, University of Georgia, ABRF, Genomatix, Illumina, Mondobiotech, 23andMe, Kapa Biosystems

Pages

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.